• Mr. Bhavesh Tare
• Dr. Gajendra Wasnik

The pharmaceutical industry, a key player in global healthcare, continually adapts to emerging technologies, changing healthcare paradigms, and societal expectations. This study delves into the financial performance of Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Torrent Pharma, and Zydus Lifesciences Ltd over the period FY 2018-19 to FY 2022-23. Using ratio analysis, mean, standard deviation, coefficient of variance, multiple regression analysis, and one-way ANOVA, the study assesses key profitability indicators. Limitations include the reliance on secondary data and the study's focus on a five-year period, which may impact the generalizability of results. The profitability of selected Indian pharmaceutical companies remained satisfactory over the study period. The results indicate a significant relationship between profitability ratios for most companies, providing valuable insights for stakeholders and decision-makers. Notably, Zydus Lifesciences Ltd stands out as an exception, with no significant relationship found in the analysis. These findings contribute to a deeper understanding of the financial dynamics within the pharmaceutical industry, aiding stakeholders in making informed decisions and shaping strategic initiatives.

Pharmaceutical industry, Financial Performance Analysis, Ratio Analysis

"Financial Evaluation of Chosen Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 2, page no.f762-f769, February-2024, Available :http://www.jetir.org/papers/JETIR2402592.pdf

"Financial Evaluation of Chosen Pharmaceutical Companies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 2, page no. ppf762-f769, February-2024, Available at : http://www.jetir.org/papers/JETIR2402592.pdf